Balance at
December 31, 2024

Additions

Deductions

Balance at
September 30, 2025

Accounts receivable and contract assets:

Billed receivables - Sanofi

$

—

$

20,947

$

(20,947

)

$

—

Unbilled receivables - Sanofi

947

20,000

(20,947

)

—

Billed receivables - Gilead

—

40,000

(40,000

)

—

Total accounts receivable and contract assets

$

947

$

80,947

$

(81,894

)

$

—

Contract liabilities:

Deferred revenue - Sanofi

$

13,576

$

20,000

$

(33,576

)

$

—

Deferred revenue - Gilead

—

40,000

(2,764

)

37,236

Total contract liabilities

$

13,576

$

60,000

$

(36,340

)

$

37,236